NBT Bank N A NY lessened its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 8.2% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 22,166 shares of the pharmacy operator’s stock after selling 1,985 shares during the quarter. NBT Bank N A NY’s holdings in Walgreens Boots Alliance were worth $1,711,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also made changes to their positions in the company. Commonwealth Bank of Australia increased its position in shares of Walgreens Boots Alliance by 139.5% during the 2nd quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock worth $3,614,000 after purchasing an additional 26,893 shares in the last quarter. Andra AP fonden increased its position in Walgreens Boots Alliance by 6.9% in the 3rd quarter. Andra AP fonden now owns 62,300 shares of the pharmacy operator’s stock valued at $4,811,000 after acquiring an additional 4,000 shares in the last quarter. IBM Retirement Fund increased its position in Walgreens Boots Alliance by 88.1% in the 2nd quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator’s stock valued at $2,004,000 after acquiring an additional 10,729 shares in the last quarter. Schwab Charles Investment Management Inc. increased its position in Walgreens Boots Alliance by 5.4% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock valued at $236,476,000 after acquiring an additional 154,995 shares in the last quarter. Finally, Birinyi Associates Inc. boosted its stake in shares of Walgreens Boots Alliance by 9.0% in the 2nd quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock valued at $713,000 after purchasing an additional 750 shares during the last quarter. Institutional investors own 61.18% of the company’s stock.
Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $75.38 on Friday. Walgreens Boots Alliance Inc has a 12 month low of $63.82 and a 12 month high of $88.00. The company has a quick ratio of 0.47, a current ratio of 0.96 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $74,600.00, a PE ratio of 20.82, a price-to-earnings-growth ratio of 1.29 and a beta of 1.22.
Walgreens Boots Alliance announced that its board has approved a stock buyback program on Wednesday, October 25th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the pharmacy operator to repurchase shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company’s management believes its stock is undervalued.
In other news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now directly owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director John Anthony Lederer bought 20,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, October 26th. The shares were acquired at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the purchase, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The disclosure for this purchase can be found here. Insiders own 14.80% of the company’s stock.
A number of research analysts have weighed in on the stock. Needham & Company LLC cut their price target on shares of Walgreens Boots Alliance to $86.00 and set a “buy” rating on the stock in a research note on Wednesday, November 22nd. Jefferies Group set a $93.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a report on Sunday, October 29th. Pivotal Research set a $73.00 target price on shares of Walgreens Boots Alliance and gave the stock a “hold” rating in a report on Friday, January 5th. Vetr upgraded shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a report on Tuesday, December 12th. Finally, BidaskClub raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday, November 10th. Nine research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company. Walgreens Boots Alliance has an average rating of “Buy” and an average price target of $86.15.
WARNING: This story was published by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this story on another publication, it was stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this story can be read at https://stocknewstimes.com/2018/01/12/walgreens-boots-alliance-inc-wba-shares-sold-by-nbt-bank-n-a-ny.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.